Cost and yield of adding electrocardiography to history and physical in screening Division I intercollegiate athletes: A 5-year experience

被引:48
作者
Malhotra, Rohit [1 ,2 ]
West, J. Jason [1 ,2 ]
Dent, John [1 ,2 ]
Luna, Max [1 ,2 ]
Kramer, Christopher M. [1 ,2 ]
Mounsey, J. Paul [4 ]
Battle, Robert [1 ,2 ]
Saliba, Ethan [3 ]
Rose, Benjamin
Mistry, Dilaawar [1 ,3 ]
MacKnight, John [1 ]
DiMarco, John. P. [1 ]
Mahapatra, Srijoy [1 ,2 ]
机构
[1] Univ Virginia, Dept Internal Med, Charlottesville, VA 22908 USA
[2] Univ Virginia, Div Cardiol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA 22908 USA
[4] Univ N Carolina, Dept Med, Div Cardiol, Chapel Hill, NC USA
关键词
Athlete; Atrial fibrillation; Electrocardiography; Screening; Supraventricular tachycardia; Ventricular tachycardia; Wolff-Parkinson-White syndrome; AMERICAN-HEART-ASSOCIATION; LONG QT SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; SUDDEN-DEATH; CARDIOVASCULAR-DISEASE; HEALTH-PROFESSIONALS; CLINICAL CARDIOLOGY; YOUNG; STATEMENT; EPINEPHRINE;
D O I
10.1016/j.hrthm.2010.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Electrocardiographic screening of intercollegiate athletes is controversial because the costs and yield are not well defined. Both the American Heart Association (AHA) and the European Society of Cardiology (ESC) have different criteria for screening, partly because the populations being screened are different. OBJECTIVE The purpose of this study was to determine the cost and yield of a 5-year ECG screening program at a United States Division I college. METHODS At the University of Virginia, all 1,473 competitive athletes over the course of 5 years were screened with history and physical and with ECGs using ESC guidelines with follow-up testing as dictated by clinical symptoms and ECG findings. RESULTS History and physical alone uncovered five significant cardiac abnormalities. ECGs were abnormal in 275 (19%), resulting in 359 additional tests. Additional testing confirmed eight significant cardiac abnormalities that were not found by history and physical: 1 bicuspid aortic valve, 4 rapidly conducting accessory pathways, 1 long QT patient, 1 with frequent premature ventricular contractions and low ejection fraction, and 1 with frequent premature ventricular contractions but normal ejection fraction. No cases of hypertrophic cardiomyopathy were found. Total cost of the program was US $894,870. Cost of history and physical screening alone was $343,725 or $68,745 per finding. The marginal cost of adding ECG screening, including resulting tests and procedures. was US$551,145 or US$68,893 per additional finding. CONCLUSION ECG screening of U. S. college athletes can uncover significant cardiac pathology not discovered by history and physical alone. Although ECG screening also results in many false positives resulting in additional tests, the overall cost per diagnosis of adding ECG screening is similar to that of history and physical screening alone.
引用
收藏
页码:721 / 727
页数:7
相关论文
共 22 条
  • [1] Cardiovascular Screening in College Athletes With and Without Electrocardiography A Cross-sectional Study
    Baggish, Aaron L.
    Hutter, Adolph M., Jr.
    Wang, Francis
    Yared, Kibar
    Weiner, Rory B.
    Kupperman, Eli
    Picard, Michael H.
    Wood, Malissa J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 269 - W79
  • [2] Prevalence of hypertrophic cardiomyopathy in highly trained athletes: Relevance to pre-participation screening
    Basavarajaiah, Sandeep
    Wilson, Matthew
    Whyte, Gregory
    Shah, Ajay
    McKenna, William
    Sharma, Sanjay
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : 1033 - 1039
  • [3] Short QT syndrome
    Brugada, R
    Hong, K
    Cordeiro, JM
    Dumaine, R
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (11) : 1349 - 1354
  • [4] Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol - Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
    Corrado, D
    Pelliccia, A
    Bjornstad, HH
    Vanhees, L
    Biffi, A
    Borjesson, M
    Panhuyzen-Goedkoop, N
    Deligiannis, A
    Solberg, E
    Dugmore, D
    Mellwig, KP
    Assanelli, D
    Delise, P
    van-Buuren, F
    Anastasakis, A
    Heidbuchel, H
    Hoffmann, E
    Fagard, R
    Priori, SG
    Basso, C
    Arbustini, E
    Blomstrom-Lundqvist, C
    McKenna, WJ
    Thiene, G
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (05) : 516 - 524
  • [5] Screening for hypertrophic cardiomyopathy in young athletes
    Corrado, D
    Basso, C
    Schiavon, M
    Thiene, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) : 364 - 369
  • [6] Recommendations for interpretation of 12-lead electrocardiogram in the athlete
    Corrado, Domenico
    Pelliccia, Antonio
    Heidbuchel, Hein
    Sharma, Sanjay
    Link, Mark
    Basso, Cristina
    Biffi, Alessandro
    Buja, Gianfranco
    Delise, Pietro
    Gussac, Ihor
    Anastasakis, Aris
    Borjesson, Mats
    Bjornstad, Hans Halvor
    Carre, Francois
    Deligiannis, Asterios
    Dugmore, Dorian
    Fagard, Robert
    Hoogsteen, Jan
    Mellwig, Klaus P.
    Panhuyzen-Goedkoop, Nicole
    Solberg, Erik
    Vanhees, Luc
    Drezner, Jonathan
    Estes, N. A. Mark, III
    Iliceto, Sabino
    Maron, Barry J.
    Peidro, Roberto
    Schwartz, Peter J.
    Stein, Ricardo
    Thiene, Gaetano
    Zeppilli, Paolo
    McKenna, William J.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (02) : 243 - 259
  • [7] Report of the NASPE policy conference on arrhythmias and the athlete
    Estes, NAM
    Link, MS
    Cannom, D
    Naccarelli, GV
    Prystowsky, EN
    Maron, BJ
    Olshansky, B
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (10) : 1208 - 1219
  • [8] Cost-Effectiveness of Mammography, MRI, and Ultrasonography for Breast Cancer Screening
    Feig, Stephen
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2010, 48 (05) : 879 - +
  • [9] Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]
  • [10] Hypertrophic cardiomyopathy - A systematic review
    Maron, BJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10): : 1308 - 1320